Semaglutide primarily mimics the GLP-1 hormone, focusing on appetite suppression
It is the active ingredient in Mounjaro (FDA-approved for type 2 diabetes) and Zepbound (FDA-approved for weight management)
The last three ingredients are common supplement additives
Because GH and IGF-1 signaling can influence fluid balance, connective tissue, metabolism, and glucose regulation, potential GH-axis-related effects include: Water retention Peripheral edema Joint stiffness or discomfort Muscle aches Paresthesias or tingling Carpal-tunnel-like symptoms Changes in insulin sensitivity or glucose handling Adult GH replacement literature consistently identifies fluid-retention-related effects including edema, arthralgia, carpal tunnel syndrome, and paresthesias as common side effects of GH treatment
Therefore, semaglutide, tirzepatide, and retatrutide are expected to be safer and more effective treatments for MC4R-deficient obesity than setmelanotide
See our detailed pages on Tesamorelin, CJC-1295 DAC, Sermorelin, Ipamorelin, GHRP-6 and Hexarelin for reconstitution protocols, referenced studies and certificates of analysis